Insurers love to call GLP-1s 'cosmetic' or 'not covered'—here's how to fight a Zepbound, Wegovy, or Saxenda denial.

Appeal Your Zepbound or GLP-1 Denial

Obesity is a disease, not a lifestyle choice—your appeal can say so.

Start Your Appeal
Chat with AI Assistant

Understanding Your Zepbound (tirzepatide) Denial

GLP-1 and GIP/GLP-1 weight-management medications like Zepbound, Wegovy, and Saxenda get denied constantly—often with a blanket 'weight-loss drug exclusion,' a 'cosmetic' label, or a step-therapy requirement. But these are FDA-approved treatments for a recognized disease, and several carry additional FDA indications (cardiovascular risk reduction, obstructive sleep apnea). A focused appeal that names the right indication and the exact plan language has a real shot at overturning the denial.

Common Reasons for Denial

  • ! Weight-loss medications are excluded under your plan
  • ! Considered cosmetic or for lifestyle
  • ! Step therapy / try other options first
  • ! Does not meet BMI or medical-necessity criteria
  • ! Non-formulary

How We Help

We help you frame your denial around the FDA-approved indication you're actually being treated for, the recognition of obesity as a disease, and the exact exclusion language in your plan—then generate an appeal letter you can submit today.

Start your GLP-1 / Zepbound appeal—it takes about 3 minutes.

Some Types of Evidence We Can Use For Supporting Your Appeal

✓ The American Medical Association recognized obesity as a chronic disease in 2013; anti-obesity medications are FDA-approved treatments rather than cosmetic products.

✓ Several GLP-1/GIP medications carry FDA-approved indications beyond weight management—for example, semaglutide (Wegovy) for reducing major cardiovascular events in adults with established cardiovascular disease, and tirzepatide (Zepbound) for moderate-to-severe obstructive sleep apnea in adults with obesity.

✓ When a plan applies a categorical weight-loss-drug exclusion, the exact plan language should be reviewed against the specific FDA-approved indication being treated.

Pharmacy Discount Options

Zepbound is usually expensive even with discount cards, so the appeal is your primary path to coverage. Discount programs below may still reduce the cost somewhat, but check the price before assuming they make the drug affordable.

GoodRx

Free discount card accepted at most US pharmacies. Compare prices across nearby pharmacies and present the GoodRx coupon at the counter.

Mark Cuban Cost Plus Drugs

Mail-order pharmacy with transparent pricing (manufacturer cost + 15% markup + dispensing fee). Carries many common generics.

Crush Cost

Free pharmacy-discount card with retail-pharmacy price lookup. Useful as a second quote alongside GoodRx since the two cards frequently come back with different prices at the same counter.

Amazon Search

Search Amazon's main retail site for over-the-counter formulations or supplies related to this medication. (This is Amazon's general product search, not the prescription Amazon Pharmacy storefront; Prime members may see discounted prices.)

Important: amounts paid out-of-pocket through discount programs typically do NOT count toward your insurance deductible or out-of-pocket maximum. Continue your appeal to get the medication covered through insurance.

Financial Assistance Directory

Curated copay foundations, manufacturer programs, and safety-net clinics that may help with the cost while you appeal.

Manufacturer copay programs

Zepbound Savings Card (Lilly)

Lilly savings program for commercially-insured patients prescribed Zepbound for chronic weight management.

Eligibility: Commercial insurance only.

General copay foundations & directories

NeedyMeds

Searchable database of 5,000+ patient assistance, copay, and diagnosis-specific programs. Start here if you are not sure where to look.

Eligibility: No eligibility check - the directory itself is free. Individual programs have their own income and insurance criteria.

Patient Advocate Foundation Co-Pay Relief

Direct copay assistance for insured patients with chronic, life-threatening, or rare conditions. Covers many disease funds.

Eligibility: Generally requires insurance coverage and income up to 400% of the federal poverty level (varies by fund).

Phone: 1-866-512-3861

HealthWell Foundation

Independent charity providing copay, premium, and travel assistance grants across 70+ disease funds.

Eligibility: Must have insurance covering the prescribed treatment; income thresholds vary by fund. Funds open and close as donations allow.

The Assistance Fund (TAF)

Copay, insurance premium, and travel assistance for patients with chronic and rare diseases.

Eligibility: Must have insurance and meet income limits (typically up to 500% FPL, fund-dependent).

Good Days

Copay assistance and other support for chronic-disease patients.

Eligibility: Funds vary by disease and open/close based on availability. Usually requires insurance and income under ~500% FPL.

PAN Foundation (Patient Access Network)

Disease-specific copay assistance funds for ~70 conditions. Funds open and close throughout the year - check the website or sign up for fund-open alerts.

Eligibility: Insurance required; income limits typically 400-500% of FPL depending on the fund.

NORD (National Organization for Rare Disorders)

Patient assistance, copay, and travel programs for people living with rare diseases.

RxAssist Patient Assistance Program Center

Comprehensive directory of manufacturer patient assistance programs. Search by medication to find the manufacturer's free-drug program if you are uninsured or under-insured.

Safety-net clinics & 340B

HRSA Find a Health Center (FQHC locator)

Federally Qualified Health Centers (FQHCs) provide primary care on a sliding-fee scale and dispense many medications at 340B-discounted prices, regardless of insurance status. Often the cheapest path for uninsured or under-insured patients.

HRSA 340B Program (provider directory + program info)

Background on the 340B Drug Pricing Program. Use to verify whether a particular clinic or hospital is a covered entity before assuming discounted pricing applies.

State Pharmaceutical Assistance Program (SPAP) directory

State-run programs (mostly for seniors and people with disabilities) that supplement Medicare Part D and reduce prescription costs. Availability and benefits vary by state.

Medicaid eligibility & application (Healthcare.gov)

If denied insurance is unaffordable, check Medicaid / CHIP eligibility - thresholds and pathways vary by state, and many expansion states cover adults up to 138% FPL.

Program eligibility, fund availability, and contact info change frequently. Verify with each organization before assuming a program is open.

Frequently Asked Questions

Often yes. Ask the plan to quote the exact exclusion language and show how it applies to the specific FDA-approved indication you're being treated for. If you're being treated for a condition like cardiovascular risk or obstructive sleep apnea, a blanket 'weight-loss' exclusion may not reach it.

Tirzepatide (Zepbound) is FDA-approved for chronic weight management and for moderate-to-severe obstructive sleep apnea in adults with obesity. Semaglutide (Wegovy) is also approved to reduce the risk of major cardiovascular events in certain adults. Naming the indication your doctor is treating can change how the plan must evaluate the claim.

The American Medical Association recognized obesity as a disease in 2013. Anti-obesity medications are FDA-approved treatments, not cosmetic products—your appeal can make that point directly and ask the reviewer to apply individualized medical-necessity criteria.

You can request a step-therapy override where preferred drugs were tried and failed, are contraindicated, or are expected to be ineffective. Your appeal should ask for the override and the plan's specific clinical criteria.

Ready to Fight Your Zepbound (tirzepatide) Denial?

Our free AI-powered tool will help you generate a compelling appeal letter in minutes.

Start Your Appeal Chat with AI Assistant

Disclaimer: Fight Health Insurance is not affiliated with, endorsed by, or partnered with any pharmaceutical manufacturer, healthcare provider, medical device company, or patient assistance program, including Eli Lilly (Zepbound); Novo Nordisk (Wegovy, Saxenda). All information provided is for educational and informational purposes only and does not constitute medical or legal advice. Please consult with your healthcare provider regarding treatment options and with your insurance company regarding coverage decisions.